Gluskin Anna E

Generex Biotechnology Corp.

CEO & Pres., Director

Avg. Two Year Performance

(37%) Avg. Purchase Return (17%) Compound

No Sale Track Record

Holdings: 1.18M shares

Last Three Months: 16-Feb-24 -- 15-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Delivery

Drugs

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions